Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19
MII Rabby - Journal of pharmacy & pharmaceutical …, 2020 - journals.library.ualberta.ca
Purpose: SARS-CoV-2 first emerged in China in December 2019 and rapidly spread
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
Current treatments and therapeutic options for COVID-19 patients: a systematic review
E Mehraeen, Z Najafi, B Hayati… - … Current Drug Targets …, 2022 - ingentaconnect.com
Introduction: COVID-19 is the third rising epidemic in the 21st century that quickly turned into
a worldwide pandemic. Many clinical studies have been achieved to investigate treatments …
a worldwide pandemic. Many clinical studies have been achieved to investigate treatments …
The rationale for potential pharmacotherapy of COVID-19
On 11 March 2020, the coronavirus disease (COVID-19) was defined by the World Health
Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the …
Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Progress in the research and development of anti-COVID-19 drugs
L Huang, Y Chen, J Xiao, W Luo, F Li, Y Wang… - Frontiers in public …, 2020 - frontiersin.org
The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and
psychological damage to global human health. COVID-19 spread rapidly around the world …
psychological damage to global human health. COVID-19 spread rapidly around the world …
[PDF][PDF] Therapeutic options for COVID-19: a review
R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - cureus.com
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …